Open label, monocentric pilot study to evaluate safety and efficacy of Bazedoxifene in addition to Standard of Care in hospitalized COVID-19 patients suffering from moderate to severe Pneumonia
Latest Information Update: 12 Sep 2023
At a glance
- Drugs Bazedoxifene (Primary)
- Indications COVID-19 pneumonia
- Focus Adverse reactions
- 27 Mar 2022 Status changed from recruiting to completed.
- 24 Mar 2021 New trial record